Older women who take menopausal hormone therapy may be at a higher risk of Alzheimer's. A study published in Science Advances ...

Lecanemab and donanemab were hailed as 'the beginning of the end' of dementia last year, after studies showed they both ...

For Alzheimer’s, blood tests for p-tau are still useful, but they should not be the only method for diagnosis. A positive ...

Researchers at Northwestern University have made a breakthrough in identifying a way for Alzheimer's disease to be treated ...

The results of a new study show that suppressing KCTD20, which responds to the neurotransmitter glutamate, activates a mechanism for expelling tau proteins.

There is no known cure for Alzheimer’s disease (AD), although prescription drug-based treatments that can slow AD progression ...

A new study from Mass General Brigham researchers has found faster accumulation of tau-a key indicator of Alzheimer's disease-in the brains of women over the age of 70 who took menopausal hormone ...

"Studies have shown that vulnerability to Alzheimer's-related changes in the brain increase in women from pre- to ...

After Eli Lilly and Biogen’s setbacks in developing O-GlaNAcase (OGA) inhibitors for Alzheimer’s disease, Asceneuron has now ...

Elevated levels of p-tau 181 and 217 in cerebrospinal fluid are considered to reflect early Alzheimer's disease pathology.

A new study by Mass General Brigham researchers has found faster accumulation of tau—a key indicator of Alzheimer's ...

Researchers identified a gene that seems to help slow brain aging in women, and studied links between hormone therapy, ...